Skip Navigation

Cardiovascular Research 2003 58(3):679-688; doi:10.1016/S0008-6363(03)00256-6
© 2003 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Aguilera, C. M
Right arrow Articles by Newby, A. C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aguilera, C. M
Right arrow Articles by Newby, A. C
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2003, European Society of Cardiology

Relationship between type IV collagen degradation, metalloproteinase activity and smooth muscle cell migration and proliferation in cultured human saphenous vein

Concepción M Aguilera, Sarah J George, Jason L Johnson and Andrew C Newby*

Bristol Heart Institute, University of Bristol, Level 7, Bristol Royal Infirmary, Bristol BS2 8HW, UK

a.newby{at}bris.ac.uk

* Corresponding author. Tel.: +44-117-928-3582; fax: +44-117-928-3581.

The relationship between degradation of basement membranes, metalloproteinase (MMP) activity and smooth muscle cell (SMC) migration and proliferation has not been previously investigated in any intervention study. We used adenoviral overexpression of tissue inhibitors of metalloproteinases (TIMPs) in cultured human saphenous veins. By immunocytochemistry, the percentage of medial SMC surrounded by basement membrane type IV collagen (Coll-IV) decreased from 93±1 to 77±4% and 82±1% (n = 18, both P<0.001) after 7 and 14 days of culture, respectively, while all SMC that migrated to the neointima lacked Coll-IV. Overexpression of TIMP-1 or TIMP-3 significantly increased the percentage of medial SMC surrounded by Coll-IV (94±2 or 98±2%, respectively, both P<0.01 vs. no treatment) and decreased the number of neointimal SMC. Some 44±18 and 30±6%, respectively, of BrdU or PCNA labeled medial SMC remained surrounded by type IV collagen and this was not affected by overexpression of TIMP-1 or TIMP-3. We conclude that MMPs mediate loss of basement membrane and this is closely related to SMC migration. SMC proliferation does not require complete basement membrane degradation, which itself does not require MMPs in proliferating SMC.

KEYWORDS Atherosclerosis; Extracellular matrix; Vein; Smooth muscle; Remodeling


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
T. Schachner, C. Steger, S. Heiss, N. Bonaros, W. Sterlacci, G. Laufer, and J. Bonatti
Paclitaxel treatment reduces neointimal hyperplasia in cultured human saphenous veins
Eur. J. Cardiothorac. Surg., December 1, 2007; 32(6): 906 - 911.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
S. Abilleira, S. Bevan, and H. S Markus
The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis
J. Med. Genet., December 1, 2006; 43(12): 897 - 901.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Schachner
Pharmacologic inhibition of vein graft neointimal hyperplasia
J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1065 - 1072.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. C. Newby
Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates
Cardiovasc Res, February 15, 2006; 69(3): 614 - 624.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. A. Petrofski, J. A. Hata, M. L. Williams, C. J. Parsa, R. B. Thompson, S. I. Hanish, T. R. Gehrig, W. J. Koch, and C. A. Milano
A G{beta}{gamma} inhibitor reduces intimal hyperplasia in aortocoronary saphenous vein grafts
J. Thorac. Cardiovasc. Surg., December 1, 2005; 130(6): 1683 - 1690.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Burgstaller and M. Gimona
Podosome-mediated matrix resorption and cell motility in vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H3001 - H3005.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. Koutsouki, C. A. Beeching, S. C. Slater, O. W. Blaschuk, G. B. Sala-Newby, and S. J. George
N-Cadherin-Dependent Cell-Cell Contacts Promote Human Saphenous Vein Smooth Muscle Cell Survival
Arterioscler Thromb Vasc Biol, May 1, 2005; 25(5): 982 - 988.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. W. Johnson, Y. X. Wu, C. Herdeg, A. Baumbach, A. C. Newby, K. R. Karsch, and M. Oberhoff
Stent-Based Delivery of Tissue Inhibitor of Metalloproteinase-3 Adenovirus Inhibits Neointimal Formation in Porcine Coronary Arteries
Arterioscler Thromb Vasc Biol, April 1, 2005; 25(4): 754 - 759.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A.H. Schoneveld, M.M. Oude Nijhuis, B. van Middelaar, J.D. Laman, D.P.V. de Kleijn, and G. Pasterkamp
Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development
Cardiovasc Res, April 1, 2005; 66(1): 162 - 169.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. C. Newby
Dual Role of Matrix Metalloproteinases (Matrixins) in Intimal Thickening and Atherosclerotic Plaque Rupture
Physiol Rev, January 1, 2005; 85(1): 1 - 31.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.